Anju John John Velvet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anju John John Velvet has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bernard Clarke
Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK
1 shared publication - Farzin Fath-Ordoubadi
Manchester University Hospitals NHS Foundation Trust, United Kingdom (F.F.-O.).
1 shared publication - Handrean Soran
Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, UK
1 shared publication - Irfan M. Ahmed
Department of Cardiology , Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK
1 shared publication - Manish Motwani
Oregon State University, Corvallis, USA
1 shared publication - Matthew J. Daniels
Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, UK; Division of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, UK; Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester, Manchester, UK
1 shared publication
Latest Publications
- Open Access
- 23 June 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (6) , omac059
A case report of a large right atrial myxoma: the role of virtual consultations and imaging during the COVID-19 pandemic
We present a case report of a right atrial myxoma first diagnosed on a transthoracic echocardiogram after telephone consultations held in lieu of face-to-face consultations during the first wave of the COVID-19 pandemic. The echocardiogram was requested on the second telephone consultation 3 months after an initial presentation with a dry cough and fatigue due to new symptoms of palpitations and shortness of breath raising suspicion of heart failure. Virtual consultations continue to replace face-to-face consultations to avoid unnecessary exposure to COVID and reduce health care costs. This case report focuses on the importance of obtaining a systematic history, identifying red flags, referring to appropriate specialties and requesting the right investigations for early diagnosis and management of conditions with serious complications.
- 23 June 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (6) , omac059
Open AccessA case report of a large right atrial myxoma: the role of virtual consultations and imaging during the COVID-19 pandemic
We present a case report of a right atrial myxoma first diagnosed on a transthoracic echocardiogram after telephone consultations held in lieu of face-to-face consultations during the first wave of the COVID-19 pandemic. The echocardiogram was requested on the second telephone consultation 3 months after an initial presentation with a dry cough and fatigue due to new symptoms of palpitations and shortness of breath raising suspicion of heart failure. Virtual consultations continue to replace face-to-face consultations to avoid unnecessary exposure to COVID and reduce health care costs. This case report focuses on the importance of obtaining a systematic history, identifying red flags, referring to appropriate specialties and requesting the right investigations for early diagnosis and management of conditions with serious complications.
- Open Access
- 1 September 2020
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2020 (9) , 310-313
Homozygous familial hypercholesterolemia with an update on cholesterol management
Familial hypercholesterolemia (FH) is an autosomal dominant condition that increases the risk of premature cardiovascular disease. Despite advances in treatment, it remains under detected and under treated. As an inherited condition, it poses a risk to the patient and family members. Most cases are due to defective low-density lipoprotein receptor (LDLR) activity. Heterozygous mutations are common (1:250–1:300). Homozygous FH is very rare (2–3 in a million), with higher circulating cholesterol levels and a poorer cardiovascular prognosis. We present the management of a case of homozygous hypercholesterolemia due to homozygous LDLR mutation. The patient subsequently developed severe coronary artery and aortic valve disease despite aggressive lipid-lowering therapy. We review advanced lipid management options that include lipoprotein apheresis, Proprotein Convertase Subtilisin/Kexin type 9 inhibition, and the microsomal triglyceride transfer protein inhibitor lomitapide.
- 1 September 2020
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2020 (9) , 310-313
Open AccessHomozygous familial hypercholesterolemia with an update on cholesterol management
Familial hypercholesterolemia (FH) is an autosomal dominant condition that increases the risk of premature cardiovascular disease. Despite advances in treatment, it remains under detected and under treated. As an inherited condition, it poses a risk to the patient and family members. Most cases are due to defective low-density lipoprotein receptor (LDLR) activity. Heterozygous mutations are common (1:250–1:300). Homozygous FH is very rare (2–3 in a million), with higher circulating cholesterol levels and a poorer cardiovascular prognosis. We present the management of a case of homozygous hypercholesterolemia due to homozygous LDLR mutation. The patient subsequently developed severe coronary artery and aortic valve disease despite aggressive lipid-lowering therapy. We review advanced lipid management options that include lipoprotein apheresis, Proprotein Convertase Subtilisin/Kexin type 9 inhibition, and the microsomal triglyceride transfer protein inhibitor lomitapide.
- Open Access
- 11 January 2019
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (4) , 437-448
A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature
A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature
- 11 January 2019
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (4) , 437-448
Open AccessA single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature
A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature